BioCardia Reports Q1 2025 Results, Details April Financing
Ticker: BCDA · Form: 10-Q · Filed: May 14, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financing, subsequent-event
TL;DR
BioCardia Q1 2025 filing shows recent financing activity in April. Keep an eye on cash burn.
AI Summary
BioCardia, Inc. filed its Q1 2025 10-Q report on May 14, 2025, detailing its financial performance for the period ending March 31, 2025. The company has been involved in subsequent events including an ATM offering and other financing activities in April 2025. BioCardia, formerly known as Tiger X Medical, Inc., is based in Sunnyvale, CA.
Why It Matters
This filing provides investors with an update on BioCardia's financial health and recent capital-raising activities, which are crucial for funding its ongoing operations and development efforts.
Risk Assessment
Risk Level: medium — The company's financial performance and cash burn rate, along with its reliance on financing, present inherent risks.
Key Numbers
- Q1 2025 — Reporting Period (Covers the first quarter of 2025, ending March 31, 2025.)
- 20250514 — Filing Date (The date BioCardia, Inc. submitted this 10-Q filing.)
Key Players & Entities
- BioCardia, Inc. (company) — Filer of the 10-Q
- Tiger X Medical, Inc. (company) — Former name of BioCardia, Inc.
- 320 Soquel Way, Sunnyvale, CA 94085 (location) — Business and mailing address
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date of the 10-Q
- April 2025 (date) — Period of subsequent financing events
FAQ
What were the key financing activities BioCardia engaged in during April 2025?
The filing indicates subsequent events including an ATM offering and other financing activities in April 2025, with specific dates like April 4, 2025, and April 22, 2025, mentioned in relation to these events.
What is the primary business of BioCardia, Inc.?
BioCardia, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did BioCardia, Inc. change its name from Tiger X Medical, Inc.?
The company changed its name from Tiger X Medical, Inc. on June 16, 2011.
What is the fiscal year end for BioCardia, Inc.?
BioCardia, Inc.'s fiscal year ends on December 31.
What is the SEC file number for BioCardia, Inc.?
The SEC file number for BioCardia, Inc. is 001-38999.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding BioCardia, Inc. (BCDA).